Search company, investor...
Amaranth Medical company logo

Amaranth Medical

amaranthmedical.com

Founded Year

2006

Stage

Corporate Minority | Dead

Total Raised

$27.5M

About Amaranth Medical

Amaranth Medical is a medical device company which has created a technology platform for the development and manufacturing of fully bioresorbable scaffolds. The Company's lead product is the FORTITUDE scaffold, which is designed to afford the strength of metal stents to assist the artery during the remodeling process following an interventional procedure, without leaving behind a permanent implant with inherent clinical limitations. Amaranth Medical is headquartered in Mountain View, California, and its research and manufacturing operations are located both in Singapore and at its Silicon Valley headquarters.

Headquarters Location

1145 Terra Bella Avenue Sutie A

Mountain View, California, 94043,

United States

650-965-3830

Missing: Amaranth Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Amaranth Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Amaranth Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Amaranth Medical is included in 1 Expert Collection, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Amaranth Medical Patents

Amaranth Medical has filed 1 patent.

The 3 most popular patent topics include:

  • Implants (medicine)
  • Angiology
  • Broadway (Manhattan)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/18/2013

1/19/2021

Implants (medicine), Casting (manufacturing), Prosthetics, Polymers, Solid mechanics

Grant

Application Date

9/18/2013

Grant Date

1/19/2021

Title

Related Topics

Implants (medicine), Casting (manufacturing), Prosthetics, Polymers, Solid mechanics

Status

Grant

Latest Amaranth Medical News

Bioabsorbable Stents Market is Expected to Witness Rapid Growth by 2022 | Abbott Laboratories, Amaranth Medical, Inc., BIOTRONIK SE & Co. KG, Elixir Medical Corporation, REVA Medical, Inc.

May 3, 2021

| Abbott Laboratories, Amaranth Medical, Inc., BIOTRONIK SE & Co. KG, Elixir Medical Corporation, REVA Medical, Inc. Future Market Insights recently published a fully researched publication on “Global Bioabsorbable Stents Market: Industry analysis (2012-2016) and Opportunity Analysis (2017-2022)”, which focuses on different aspects which influence the global market. The comprehensive research report on global bioabsorbable stents market focuses on trends, opportunities, challenges, restraints and growth drivers which have a one of a kind impact on the growth of the global market. The research report presents a holistic angle covering the global scenario, thereby putting across a 3600 view of the global bioabsorbable stents market. Global scenario is covered with respect to important geographies of North America, Asia Pacific excluding Japan (APEJ), Latin America, Europe, Japan and Middle East and Africa (MEA). A detailed level five segmentation adds to the credibility and the value addition that the research report brings. Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4819 Market Taxonomy: Global bioabsorbable stents market is segmented on the basis of product type, by end user, by disease indication, by absorption rate and by region. Region Know What your Competition Knows Research report on global bioabsorbable stents market is well crafted and includes a separate section titled competitive analysis, which covers all details about the tier companies involved in the global bioabsorbable stents market. An in-depth analyses on these key companies includes a detailed SWOT, market share analysis, growth strategies, promotion tactics, mergers and acquisitions, expansion strategies, global presence, innovations and developments, etc. This competitive scenario will reinforce the reader’s decisions to gain competitive edge. To achieve this clarity and get acquainted with the various market components, and elements which impact the market, a powerful research approach is followed at Future Market Insights, which has proven useful in gathering data and achieving high accuracy of the results provided in the report. Initial steps to understand the market and get a certain direction based on the market definition is achieved with the help of secondary research. This vast research covers a wide angle of the market and points in the right direction based on which primary research is carried out. Across all important geographies, several primary interviews are conducted which give a shape to the current market understanding based on which inferences are slated. Moreover, each insight, each data point or each statement which is noted is cross checked at every stage in the primary research, re-evaluated during each primary interview and thereby all the data undergoes validation a couple of times. Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-4819 The key opinions from the market observers, industry experts and secondary sources are chalked and this extensive information overload is triangulated to arrive at conclusions with maximum accuracy. The research process includes profiling of the market, identifying and listing respondents, preparing a detailed conversation guide based on overall market understanding, collection of data points, validating the data and analysing it and providing meaningful insights. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Centrifugal Blood Pump Market – A slew of cardiovascular products were launched for the management of cardiacdisorders over the last decade and development of more are currently underway.With leading manufacturers expecting the demand to surge amid COVID-19,centrifugal blood pump sales are set to grow steadily through 2030. Pharmaceutical Intermediates Market – The global diabetes prevalence in 2019 is estimated to be 9.3% (463 millionpeople), rising to 10.2% (578 million) by 2030, and the number is risingrapidly. Pharmaceutical drugs have remained key to management of chronicdiseases and other diseases. Respiratory Inhaler Devices Market – A slew of new drugs were launched for the management of asthma and COPD overthe last decade and development of more are currently underway. With leadingdrug manufacturers expecting the demand to surge amid COVID-19, respiratoryinhaler sales are set to grow steadily through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150 countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Amaranth Medical Frequently Asked Questions (FAQ)

  • When was Amaranth Medical founded?

    Amaranth Medical was founded in 2006.

  • Where is Amaranth Medical's headquarters?

    Amaranth Medical's headquarters is located at 1145 Terra Bella Avenue, Mountain View.

  • What is Amaranth Medical's latest funding round?

    Amaranth Medical's latest funding round is Corporate Minority.

  • How much did Amaranth Medical raise?

    Amaranth Medical raised a total of $27.5M.

  • Who are the investors of Amaranth Medical?

    Investors of Amaranth Medical include Boston Scientific, Charter Life Sciences, EDBI, DCP Management of Singapore, PhillipCapital and 3 more.

  • Who are Amaranth Medical's competitors?

    Competitors of Amaranth Medical include Tepha, Noraker, Endologix, IntraOp Medical, TriReme Medical and 13 more.

Compare Amaranth Medical to Competitors

B
BioControl

BioControl - New generation of active implantable devices affecting the behavior of muscles and nerves of the autonomic nervous system. The company sold its urology business for $90M to American Medical Systems.

A
Astratech

Astra Tech develops and manufactures advanced healthcare devices and medical implants. The company aims to design products that improve the quality of life of those who use them, and to provide solutions that reduce the overall cost of care. Extensive experience, cross-disciplinary research and strictly controlled clinical trials are central to the company's business. In recent years, the company has invested heavily in integrating medical research with modern materials engineering, creating products with properties.

R
Reva Medical

REVA Medical develops interventional medical devices that leverage the company's stent designs and biomaterials to improve the treatment of vascular disease. Its flagship product is called MOTIV, a bioresorbable coronary stent that is designed to fulfill the temporary need for a stent and then fade away, leaving only the healed vessel behind. This product is utilized for the treatment of coronary artery disease. REVA Medical has a broad strategic relationship with Boston Scientific Corporation, a worldwide developer and marketer of interventional medical devices. The company was founded in 1998 and is based in San Diego, California.

A
Afferent

Afferent Corporation, based in Providence, Rhode Island, is developing of a new class of medical devices to treat chronic neurologic dysfunction. Its lead technology enhances the function of mechanoreceptor cells involved in sensory perception as a means to restore brain function following a stroke, to address complications resulting from diabetic neuropathy, and to improve elderly balance. Afferent's development efforts are being pursued in collaboration with leading biomedical and clinical researchers throughout the United States. Building on this technology platform, Afferent aims to establish a leadership position in the emerging field of neurotherapeutic devices.

A
Artificial Airways

Artificial Airways is a Texas-based "C" corporation formed to commercialize a range of medical devices developed by Dr. Angel at the UT Health Science Center in San Antonio. Airtificial Airways' devices incorporate "stent" technologies to address critical needs in the performance of existing pulmonary and cardiovascular devices - unmet needs that result in frequent, expensive and life-threatening medical complications.

C
CryoPen

CryoPen is a developer and manufacturer of state-of-the art medical devices and aesthetic treatment systems. CryoPen is committed to delivering the most effective, and profitable solutions available to healthcare providers, physicians of all specialties, and medical spas. The company's product portfolio aims to enable physicians to provide a higher quality of care and offer their patients a more diverse array of treatments while generating a substantial revenue stream for their practice. CryoPen's product set addresses a multitude of treatment applications such as laser hair removal, skin rejuvenation, cryosurgery, cellulite reduction, vascular lesions, pigmented lesions, acne, psoriasis, fine lines & wrinkles, scar and tattoo removal, photo facials, and skin tightening. With a dedication to the research and development of technologically advanced devices and equipment, every CryoPen product is designed to create a better patient experience, consistent clinical outcomes, and economic impact on the bottom line of their practice.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.